Zacks Research Has Pessimistic Outlook of MTD Q4 Earnings

Mettler-Toledo International, Inc. (NYSE:MTD) – Investment analysts at Zacks Research cut their Q4 2025 earnings per share estimates for shares of Mettler-Toledo International in a research note issued on Friday, October 24th. Zacks Research analyst Team now expects that the medical instruments supplier will earn $13.10 per share for the quarter, down from their prior estimate of $13.23. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $42.71 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q1 2027 earnings at $9.63 EPS, Q3 2027 earnings at $12.74 EPS and FY2027 earnings at $51.67 EPS.

MTD has been the subject of a number of other research reports. Bank of America boosted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Barclays boosted their price target on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. JPMorgan Chase & Co. boosted their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Finally, Evercore ISI boosted their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $1,336.50.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,420.12 on Monday. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,454.68. The stock has a market capitalization of $29.25 billion, a P/E ratio of 35.96, a price-to-earnings-growth ratio of 4.31 and a beta of 1.37. The stock has a fifty day moving average of $1,299.33 and a 200-day moving average of $1,211.88.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same period in the prior year, the company posted $9.65 EPS. The company’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently made changes to their positions in the stock. Versant Capital Management Inc increased its stake in shares of Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. increased its stake in shares of Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares during the period. WPG Advisers LLC acquired a new stake in shares of Mettler-Toledo International in the first quarter valued at about $41,000. NewSquare Capital LLC increased its stake in shares of Mettler-Toledo International by 94.4% in the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares during the period. Finally, MV Capital Management Inc. increased its stake in shares of Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares of the company’s stock, valued at $6,389,588.55. This represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is currently owned by insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.